Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Emerging Investigator Awardee
Emerging Investigator Awardee
Back
Scientific Session

Vasculitis
General Topic: Clinical Science

17S48: Development of Treatment Response Criteria for Giant Cell Arteritis

Sunday, November 17, 2024
3:30 PM – 5:00 PM Eastern Time
Location: Ballroom A
CE: 1.5

CME In Person On Demand

    Moderator(s)

  • MB

    Michelle Burke, APRN, CNP, MS

    Mayo Clinic
    Rochester, Minnesota, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • Carol Langford, MD, MHS

    Cleveland Clinic
    Moreland Hills, Ohio, United States

    Disclosure(s): AbbVie: Non-paid consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing)

Giant cell arteritis (GCA) is one of the important forms of vasculitis diagnosed and treated by rheumatologists. There is an increasing number of drugs trials but currently no internationally accepted outcome measures for GCA. EULAR and the ACR have funded a project to develop new response criteria for GCA and the challenges and process of developing these will be discussed in this session.

Learning Objectives:

  • Explain to a colleague the current outcome assessments used in GCA trials
  • Outline the challenges in developing response criteria in GCA
  • Discuss the steps for developing an international response criteria for GCA

Presentations:

  • 3:30 PM – 4:00 PM Eastern Time
    Outcome Assessment in Giant Cell Arteritis Clinical Trials and Observational Studies

    Speaker: Milena Bond, MD – Azienda sanitaria dell'Alto Adige

  • 4:00 PM – 4:30 PM Eastern Time
    Challenges Related to the Measurement of Treatment Response in GCA

    Speaker: Christian Dejaco, MD, PhD, MBA – Azienda Sanitaria Alto Adige

  • 4:30 PM – 5:00 PM Eastern Time
    Methodological Steps for the Development of Response Criteria in Giant Cell Arteritis

    Speaker: Zahi Touma, MD, PhD – University of Toronto